Ottawa Hospital Research Institute

Retinal disease

	“Dream team” of researchers tackles leading cause of vision loss July 27, 2022 - Dr. Catherine Tsilfidis has assembled a world-class team to bring discoveries with game-changing potential to patients with retinal disease
	$2.4 M grant to help researchers develop gene and cell therapies for a leading cause of blindness September 15, 2021 - A team led by Dr. Catherine Tsilfidis has received $2.4 M from the Ontario Research Fund to develop treatments for retinal diseases, a leading cause of blindness.
	The Ottawa Hospital awarded six CIHR grants worth $2.6 million September 7, 2020 - Could a common diabetes drug help prevent ovarian cancer? Can a tailored screening program help prevent eye disease in immigrants? Is sepsis different in females versus males, and if so, can this help us develop better treatments? These are just a fe

Name	Scientific appointment	Diseases, conditions and populations of interest	Research and clinical approaches
Mattar, Pierre PhD	Scientist (Regenerative Medicine)	Ataxia, Autism, Glaucoma, Intellectual disabilities, Macular degeneration, Retinal disease, Vision	Basic research, Bioinformatics, Cell therapy, Epigenetics, Gene expression, Genetics, Genomics, Model organisms, Molecular and cellular biology, Proteomics, Regenerative medicine, Stem cells, Systems biology, Transgenic/knockout models
Presseau, Justin PhD	Senior Scientist (Clinical Epidemiology)	COVID-19, Diabetes, Hepatitis C, Retinal disease, Vision	Artificial intelligence and data science, Patient engagement, Psychometrics, Qualitative methods, Quality Improvement, Transfusions, Transplantation, Behaviour, Psychology, Health professional behaviour change, Knowledge translation and implementation research, Health promotion, Cluster randomized trials, Surveys
Tsilfidis, Catherine PhD	Senior Scientist (Neuroscience)	Vision, Retinal disease, Glaucoma	Molecular and cellular biology, Disease models